Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)

British Journal of Cancer

Volumn 109, Issue 10, 2013, Pages 2554-2559

  Nicholson, S ^a   Hall, E ^b   Harland, S J ^c   Chester, J D ^d,j   Pickering, L ^e   Barber, J ^f   Elliott, T ^g   Thomson, A ^h   Burnett, S ^b   Cruickshank, C ^b   Carrington, B ^g   Waters, R ^b   Bahl, A ⁱ  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e ST GEORGE S HOSPITAL   (United Kingdom)

^f VELINDRE CANCER CENTRE   (United Kingdom)

^g CHRISTIE HOSPITAL   (United Kingdom)

^h ROYAL CORNWALL HOSPITAL   (United Kingdom)

ⁱ BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^j CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; ASTHENIA; CANCER REGRESSION; CLINICAL ARTICLE; DIARRHEA; FAINTNESS; FEBRILE NEUTROPENIA; FOLLOW UP; HUMAN; LEUKOPENIA; MALE; METASTASIS; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PENIS CANCER; PERIPHERAL EDEMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEPSIS; SQUAMOUS CELL CARCINOMA; UNITED KINGDOM;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE PROGRESSION; FLUOROURACIL; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PENILE NEOPLASMS; SURVIVAL ANALYSIS; TAXOIDS;

EID: 84887854523     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.620     Document Type: Article

References (18)

1. A'Hern R (2001) Sample size tables for exact single stage Phase II designs. Stat Med 20: 859-866.
2. Ahmed T, Sklaroff R, Yagoda A (1984) Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer. J Urol 132(3): 465-468.
3. Bermejo C, Busby JE, Spiess PE, Heller L, Pagliaro LC, Pettaway CA (2007) Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 177(4): 1335-1338.
4. Cancer Research UK (2013) UK Cancer Incidence (2010) by Country Summary, April.
5. Di Lorenzo G, Buonerba C, Federico P, Perdonà S, Aieta M, Rescigno P, D'Aniello C, Puglia L, Petremolo A, Ferro M, Marinelli A, Palmieri G, Sonpavde G, Mirone V, De Placido S (2012) Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis. BJU Int (2012) 110(11 Pt B): E661-E666.
6. Fisher H, Barada J, Horton J (1990) Neoadjuvant therapy with cisplatin and 5-fluoruracil for stage III squamous cell carcinoma of the penis. Acta Oncol 27(53): A652.
7. Gagliano RG, Blumenstein BA, Crawford ED, Stephens RL, Coltman Jr. CA, Costanzi JJ (1989) cis-Diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: a Southwest Oncology Group Study. J Urol 141(1): 66-67.
8. Hussein A, Benedetto P, Sridhar K (1990) Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 65(3): 433-438.
9. Joerger M, Warzinek T, Klaeser B, Kluckert JT, Schmid HP, Gillessen S (2004) Major tumour regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 63(4): 778-780.
10. Pagliaro LC, Williams DL, Daliani D, Williams MB, Osai W, Kincaid M, Wen S, Thall PF, Pettaway CA (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 28(24): 3851-3857.
11. Pizzocaro G, Nicolai N, Milani A (2009) Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol 55(3): 546-551.
12. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris Jr. CM, Haddad RI (2007) Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer. N Engl J Med 357(17): 1705-1715.
13. Salvioni R, Nicolai N, Piva L, Catanzaro M, Torelli T, Biasoni D, Stagni S, Milani A, Necchi A (2011) Pilot study of cisplatin, 5-fluorouracil, and a taxane (TPF) for advanced squamous cell carcinoma (SCC) of the penis. J Clin Oncol 29(suppl): (abstr 4639).
14. Shammas FV, Ous S, Fossa SD (1992) Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 147(3): 630-632.
15. Sklaroff RB, Yagoda A (1979) Cis-diamminedichloride platinum II (DDP) in the treatment of penile carcinoma. Cancer 44(5): 1563-1565.
16. Sobin L, Wittekind C (2002) TNM Classification of Malignant Tumours. 6th edn, Wiley-Liss: New York, NY, USA.
17. Theodore C, Skoneczna I, Bodrogi I, Leahy M, Kerst JM, Collette L, Ven K, Marréaud S, Oliver RD (2008) A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol 19(7): 1304-1307.
18. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL (2007) Cisplatin, Fluorouracil, and Docetaxel in unresectable head and neck cancer. N Engl J Med 357(17): 1695-1704.